Sage Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND

Report date

6/30/2025

Quarter

2025 Q2

Filed

10/8/2025

Shares

12,046

Value ($000)

110

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	10/8/2025	110	0.0%	12,046	6/30/2025
2025 Q1	10/8/2025	96	0.0%	12,046	3/31/2025
2024 Q4	10/8/2025	65	0.0%	12,046	12/31/2024
2024 Q3	10/8/2025	87	0.0%	12,046	9/30/2024
2024 Q2	10/8/2025	235	0.0%	21,646	6/30/2024
2024 Q1	10/8/2025	418	0.0%	22,283	3/31/2024
2023 Q4	10/8/2025	486	0.0%	22,421	12/31/2023
2023 Q3	10/8/2025	467	0.0%	22,688	9/30/2023
2023 Q2	10/8/2025	1,049	0.0%	22,309	6/30/2023
2023 Q1	10/8/2025	1,181	0.0%	28,151	3/31/2023
2022 Q4	10/8/2025	1,490	0.0%	39,058	12/31/2022
2022 Q3	11/8/2022	1,529	0.0%	39,051	9/30/2022
2022 Q2	8/4/2022	1,179	0.0%	36,508	6/30/2022
2022 Q1	7/1/2022	2,415	0.0%	72,946	3/31/2022
2021 Q4	2/2/2022	2,937	0.0%	69,033	12/31/2021
2021 Q3	11/2/2021	3,161	0.0%	71,347	9/30/2021
2021 Q2	8/2/2021	6,929	0.0%	121,965	6/30/2021
2021 Q1	5/11/2021	9,426	0.0%	125,936	3/31/2021
2020 Q4	2/8/2021	11,881	0.0%	137,336	12/31/2020
2020 Q3	11/5/2020	7,925	0.0%	129,669	9/30/2020
2020 Q2	8/7/2020	4,928	0.0%	118,526	6/30/2020
2020 Q1	5/6/2020	5,539	0.0%	192,879	3/31/2020
2019 Q4	2/5/2020	15,536	0.0%	215,212	12/31/2019